HealthDay on MSN18h
Risk for Chronic Fatigue Syndrome Higher After COVID-19The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.
News Medical on MSN23h
Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiencyResearchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback